These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 22853925
21. Association between VEGF gene promoter polymorphisms and bladder cancer: An updated meta-analysis. Chen CH, Ho CH, Kuan-Hua Huang S, Shen CH, Wu CC, Wang YH. Cytokine; 2020 Jul; 131():155112. PubMed ID: 32361400 [Abstract] [Full Text] [Related]
23. Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis. Hou Q, Li MY, Huang WT, Wei FF, Peng JP, Lou MW, Qiu JG. Oncotarget; 2017 Jul 25; 8(30):50061-50070. PubMed ID: 28562357 [Abstract] [Full Text] [Related]
24. No correlation between TIMP2 -418 G>C polymorphism and increased risk of cancer: evidence from a meta-analysis. Mandal RK, Akhter N, Haque S, Panda AK, Mittal RD, Alqumber MA. PLoS One; 2014 Jul 25; 9(8):e88184. PubMed ID: 25136829 [Abstract] [Full Text] [Related]
25. Investigation on association between five common polymorphisms in vascular endothelial growth factor and prototypes of autoimmune diseases. Che N, Li Y, Liu S, Pan W, Liu Y. Immunobiology; 2015 Jun 25; 220(6):722-33. PubMed ID: 25641412 [Abstract] [Full Text] [Related]
26. Four polymorphisms of VEGF (+405C>G, -460T>C, -2578C>A, and -1154G>A) in susceptibility to psoriasis: a meta-analysis. Qi M, Huang X, Zhou L, Zhang J. DNA Cell Biol; 2014 Apr 25; 33(4):234-44. PubMed ID: 24678886 [Abstract] [Full Text] [Related]
28. Vascular endothelial growth factor +936C/T polymorphism and breast cancer risk: a meta-analysis of 13 case-control studies. Yan Y, Liang H, Li T, Guo S, Li M, Li S, Qin X. Tumour Biol; 2014 Mar 25; 35(3):2687-92. PubMed ID: 24390659 [Abstract] [Full Text] [Related]
31. TIMP-2 G-418C polymorphism and cancer risk: A meta-analysis. Zhang S, Gao X, Yang J, Ji Z. J Cancer Res Ther; 2015 Mar 25; 11(2):308-12. PubMed ID: 26148591 [Abstract] [Full Text] [Related]
32. VEGF -460C>T polymorphism and cancer risk: a meta-analysis. Xu B, Feng NH, Tong N, Wang ZD, Zhang W, Wu HF, Hua LX. Med Oncol; 2010 Dec 25; 27(4):1031-6. PubMed ID: 19816815 [Abstract] [Full Text] [Related]
33. Current evidences on vascular endothelial growth factor polymorphisms and breast cancer susceptibility. Qiu LX, Wang K, Yang S, Mao C, Zhao L, Yao L, Zhang J, Zhang QL, Sun S, Xue K. Mol Biol Rep; 2011 Oct 25; 38(7):4491-4. PubMed ID: 21127992 [Abstract] [Full Text] [Related]
38. Association of Vascular Endothelial Growth Factor Gene Polymorphism With Renal Cell Carcinoma Risk. Zhou JQ, Kang XL, Wang Y, Xu CJ. Technol Cancer Res Treat; 2017 Dec 25; 16(6):978-986. PubMed ID: 28593813 [Abstract] [Full Text] [Related]
39. IL-1β+3953C/T, -511T/C and IL-6 -174C/G polymorphisms in association with tuberculosis susceptibility: A meta-analysis. Mao X, Ke Z, Liu S, Tang B, Wang J, Huang H, Chen S. Gene; 2015 Nov 15; 573(1):75-83. PubMed ID: 26169021 [Abstract] [Full Text] [Related]
40. Three Polymorphisms of Vascular Endothelial Growth Factor (+936C > T, -460C > T, and -2578C > A) and Their Susceptibility to Ovarian Cancer: A Meta-Analysis. Zhang X, Qin J, Qin A. Int J Gynecol Cancer; 2015 Jun 15; 25(5):779-85. PubMed ID: 25835351 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]